• by OMMA Editors , September 12, 2021

AstraZeneca heard social media buzz during the pandemic many patients at risk for cardiovascular did not seek medical care after experiencing symptoms of a heart attack. To change that behavior, the company created a brand awareness campaign for its oral antiplatelet drug, BRILINTA. AstraZeneca tapped HealixGlobal and Tremor Video, launching it’s first data-driven one-to-one TV retargeting ad campaign across mobile, desktop and tablets. It ran during the Super Bowl, and five days following. The campaign reached 3.7 million unique devices, and captivated users with an 84% overall VCR.